Attention-Deficit/Hyperactivity Disorder (ADHD) and High Risk Behaviors

authors:

avatar Nour-Mohammad Bakhshani ORCID 1 , *

Department of Clinical Psychology, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran

how to cite: Bakhshani N. Attention-Deficit/Hyperactivity Disorder (ADHD) and High Risk Behaviors. Int J High Risk Behav Addict. 2013;2(1): 1-2. https://doi.org/10.5812/ijhrba.12817.

References

  • 1.

    Risk and protection in successful outcomes among disadvantaged adolescents. Appl Dev Sci. 1998;2(4):194-208.

  • 2.

    Bidwell LC, McClernon FJ, Kollins SH. Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav. 2011;99(2):262-74. [PubMed ID: 21596055]. https://doi.org/10.1016/j.pbb.2011.05.002.

  • 3.

    Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 2000.

  • 4.

    Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361-9. [PubMed ID: 16950217]. https://doi.org/10.1016/j.biopsych.2006.06.011.

  • 5.

    Biederman J, Mick E, Faraone S, Hammerness P, Surman C, Harpold T, et al. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2006;26(2):163-6. [PubMed ID: 16633145]. https://doi.org/10.1097/01.jcp.0000204139.20417.8a.

  • 6.

    Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50(7):565-76. [PubMed ID: 8317950].

  • 7.

    Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-23. [PubMed ID: 16585449]. https://doi.org/10.1176/appi.ajp.163.4.716.

  • 8.

    Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-64. [PubMed ID: 17768285]. https://doi.org/10.1001/archpedi.161.9.857.

  • 9.

    Nijmeijer JS, Minderaa RB, Buitelaar JK, Mulligan A, Hartman CA, Hoekstra PJ. Attention-deficit/hyperactivity disorder and social dysfunctioning. Clin Psychol Rev. 2008;28(4):692-708. [PubMed ID: 18036711]. https://doi.org/10.1016/j.cpr.2007.10.003.

  • 10.

    Willcutt EG, Pennington BF, Chhabildas NA, Friedman MC, Alexander J. Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins. J Am Acad Child Adolesc Psychiatry. 1999;38(11):1355-62. [PubMed ID: 10560221]. https://doi.org/10.1097/00004583-199911000-00009.

  • 11.

    Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9(3):711-26. [PubMed ID: 10944664].

  • 12.

    Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36(1):37-44. [PubMed ID: 9000779]. https://doi.org/10.1097/00004583-199701000-00015.

  • 13.

    Riggs PD, Mikulich SK, Whitmore EA, Crowley TJ. Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug Alcohol Depend. 1999;54(3):195-205. [PubMed ID: 10372793].

  • 14.

    Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res. 2007;38(1):113-28. [PubMed ID: 17303170]. https://doi.org/10.1016/j.jsr.2006.09.004.

  • 15.

    Flory K, Molina BS, Pelham WE, Jr, Gnagy E, Smith B. Childhood ADHD predicts risky sexual behavior in young adulthood. J Clin Child Adolesc Psychol. 2006;35(4):571-7. [PubMed ID: 17007602]. https://doi.org/10.1207/s15374424jccp3504_8.

  • 16.

    Rosenbloom T, Wultz B. Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers. Accid Anal Prev. 2011;43(1):128-33. [PubMed ID: 21094306]. https://doi.org/10.1016/j.aap.2010.08.002.

  • 17.

    Toplak ME, Connors L, Shuster J, Knezevic B, Parks S. Review of cognitive, cognitive-behavioral, and neural-based interventions for Attention-Deficit/Hyperactivity Disorder (ADHD). Clin Psychol Rev. 2008;28(5):801-23. [PubMed ID: 18061324]. https://doi.org/10.1016/j.cpr.2007.10.008.

  • 18.

    Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57(11):1336-46. [PubMed ID: 15950006]. https://doi.org/10.1016/j.biopsych.2005.02.006.

  • 19.

    Uekermann J, Kraemer M, Abdel-Hamid M, Schimmelmann BG, Hebebrand J, Daum I, et al. Social cognition in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev. 2010;34(5):734-43. [PubMed ID: 19857516]. https://doi.org/10.1016/j.neubiorev.2009.10.009.

  • 20.

    Daviss WB. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol. 2008;18(6):565-71. [PubMed ID: 19108661]. https://doi.org/10.1089/cap.2008.032.